Skip to main content
Premium Trial:

Request an Annual Quote

SAIC-Frederick Awards Contract to Precision Antibody

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Precision Antibody announced today it has been selected by SAIC-Frederick to supply antibody and antigen characterization for the National Cancer Institute's proteomics initiative.

Precision will assist SAIC-Frederick with the characterization of newly developed monoclonal antibodies, as well as antigens, as part of the NCI's Clinical Proteomic Technologies for Cancer program. The project will include surface plasmon resonance analysis.

Precision will perform full kinetic analyses of antigen-antibody interactions "by determining real-time on- and off-rates and affinity constants of selected antibody-antigen pairs," the company said in a statement. Other methods of characterizations also will be used, including ELISA, Western blot analyses, isotyping, and antigen characterization by SDS-PAGE, the company added.

Terms of the contract were not disclosed.

CPTC is a five-year, $104 million initiative created by the NCI in 2005 to explore how proteomics can be used in cancer research. One of the projects of the program is to develop a standardized resource of highly-characterized, high-quality reference antibodies generated against cancer-associated proteins.

The antibodies will be made available to the research community along with characterization data "intended to support replication and standardization," Precision said.

The contract is the second awarded to Precision under NCI's CPTC initiative, following a contract given in October to develop monoclonal antibodies for 20 cancer-related target proteins.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.